BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: John T, Lomeli N, Bota DA. Systemic cisplatin exposure during infancy and adolescence causes impaired cognitive function in adulthood. Behav Brain Res 2017;319:200-6. [PMID: 27851909 DOI: 10.1016/j.bbr.2016.11.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Krutskikh EP, Potanina DV, Samoilova NA, Gryaznova MV, Sadovnikova IS, Gureev AP, Popov VN. Brain Protection by Methylene Blue and Its Derivative, Azur B, via Activation of the Nrf2/ARE Pathway in Cisplatin-Induced Cognitive Impairment. Pharmaceuticals 2022;15:815. [DOI: 10.3390/ph15070815] [Reference Citation Analysis]
2 Zhao Y, Wang Y, Yang D, Suh K, Zhang M. A Computational Framework to Characterize the Cancer Drug Induced Effect on Aging Using Transcriptomic Data. Front Pharmacol 2022;13:906429. [DOI: 10.3389/fphar.2022.906429] [Reference Citation Analysis]
3 Boullon L, Abalo R, Llorente-berzal Á. Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment. Front Pharmacol 2021;12:734613. [DOI: 10.3389/fphar.2021.734613] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
4 John J, Kinra M, Mudgal J, Viswanatha GL, Nandakumar K. Animal models of chemotherapy-induced cognitive decline in preclinical drug development. Psychopharmacology (Berl) 2021;238:3025-53. [PMID: 34643772 DOI: 10.1007/s00213-021-05977-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Das A, Ranadive N, Kinra M, Nampoothiri M, Arora D, Mudgal J. An Overview on Chemotherapy-induced Cognitive Impairment and Potential Role of Antidepressants. Curr Neuropharmacol 2020;18:838-51. [PMID: 32091339 DOI: 10.2174/1570159X18666200221113842] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
6 Du J, Zhang A, Li J, Liu X, Wu S, Wang B, Wang Y, Jia H. Doxorubicin-Induced Cognitive Impairment: The Mechanistic Insights. Front Oncol 2021;11:673340. [PMID: 34055643 DOI: 10.3389/fonc.2021.673340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
7 Schuitema I, Alexander T, Hudson MM, Krull KR, Edelstein K. Aging in Adult Survivors of Childhood Cancer: Implications for Future Care. J Clin Oncol 2021;39:1741-51. [PMID: 33886351 DOI: 10.1200/JCO.20.02534] [Reference Citation Analysis]
8 Hosseinzadeh M, Alizadeh A, Heydari P, Kafami M, Hosseini M, Beheshti F, Marefati N, Ghanbarabadi M. Effect of vitamin E on cisplatin-induced memory impairment in male rats. Acta Neuropsychiatr 2021;33:43-8. [PMID: 33054896 DOI: 10.1017/neu.2020.34] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Cardoso C, Kiel S, Rodrigues P, Sampaio A, Dias E, Medeiros L, Moretti R, Martins M, Bondan E. P.651 Late memory losses and glial changes in early adulthood caused by doxorubicin administration in infant rats. European Neuropsychopharmacology 2020;40:S368-9. [DOI: 10.1016/j.euroneuro.2020.09.477] [Reference Citation Analysis]
10 Staff NP, Cavaletti G, Islam B, Lustberg M, Psimaras D, Tamburin S. Platinum-induced peripheral neurotoxicity: From pathogenesis to treatment. J Peripher Nerv Syst 2019;24 Suppl 2:S26-39. [PMID: 31647151 DOI: 10.1111/jns.12335] [Cited by in Crossref: 17] [Cited by in F6Publishing: 32] [Article Influence: 8.5] [Reference Citation Analysis]
11 Ongnok B, Chattipakorn N, Chattipakorn SC. Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions. Exp Neurol 2020;324:113118. [PMID: 31756316 DOI: 10.1016/j.expneurol.2019.113118] [Cited by in Crossref: 14] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
12 Matsos A, Johnston I. Chemotherapy-induced cognitive impairments: A systematic review of the animal literature. Neuroscience & Biobehavioral Reviews 2019;102:382-99. [DOI: 10.1016/j.neubiorev.2019.05.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 25] [Article Influence: 5.3] [Reference Citation Analysis]
13 Shi L, Du FL, Sun ZW, Zhang L, Chen YY, Xie TM, Li PJ, Huang S, Dong BQ, Zhang MM. Radiation-induced gray matter atrophy in patients with nasopharyngeal carcinoma after intensity modulated radiotherapy: a MRI magnetic resonance imaging voxel-based morphometry study. Quant Imaging Med Surg 2018;8:902-9. [PMID: 30505719 DOI: 10.21037/qims.2018.10.09] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
14 Jiang N, Meng C, Han X, Guo J, Li H, Yu Z. Low-dose cisplatin causes growth inhibition and loss of autophagy of rat astrocytes in vitro. Neuroscience Letters 2018;682:112-7. [DOI: 10.1016/j.neulet.2018.06.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
15 Gaspar N, Occean BV, Pacquement H, Bompas E, Bouvier C, Brisse HJ, Castex MP, Cheurfa N, Corradini N, Delaye J, Entz-Werlé N, Gentet JC, Italiano A, Lervat C, Marec-Berard P, Mascard E, Redini F, Saumet L, Schmitt C, Tabone MD, Verite-Goulard C, Le Deley MC, Piperno-Neumann S, Brugieres L; SFCE (Société Française des Cancers de l'Enfant et l'adolescent)., GSF-GETO (Groupe Sarcome Français)., UNICANCER sarcoma group. Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/sarcome-09 study. Eur J Cancer 2018;88:57-66. [PMID: 29190507 DOI: 10.1016/j.ejca.2017.09.036] [Cited by in Crossref: 24] [Cited by in F6Publishing: 44] [Article Influence: 4.8] [Reference Citation Analysis]